TTM
$9.51B
YoY change
+2.3%
5Y CAGR
+7.2%
Peak year (2025)
$9.47B
Cumulative revenue
$103.36B
Revenue history chart for Zoetis (ZTS) from 2009 to 2025
Latest: $9.47B
Revenue growth chart for Zoetis (ZTS) from 2009 to 2025
Latest: +2.3%
Revenue history table for Zoetis (ZTS) from 2009 to 2025
| 2025 | $9.47B | +2.3% | +$211.00M | ||
| 2024 | $9.26B | +8.3% | +$712.00M | ||
| 2023 | $8.54B | +5.7% | +$464.00M | ||
| 2022 | $8.08B | +3.9% | +$304.00M | ||
| 2021 | $7.78B | +16.5% | +$1.10B | ||
| 2020 | $6.67B | +6.6% | +$415.00M | ||
| 2019 | $6.26B | +7.5% | +$435.00M | ||
| 2018 | $5.83B | +9.8% | +$518.00M | ||
| 2017 | $5.31B | +8.6% | +$419.00M | ||
| 2016 | $4.89B | +2.6% | +$123.00M | ||
| 2015 | $4.76B | -0.4% | −$20.00M | ||
| 2014 | $4.79B | +4.9% | +$224.00M | ||
| 2013 | $4.56B | +5.2% | +$225.00M | ||
| 2012 | $4.34B | +2.4% | +$103.00M | ||
| 2011 | $4.23B | +18.2% | +$651.00M | ||
| 2010 | $3.58B | +29.8% | +$822.00M | ||
| 2009 | $2.76B | — | — |
- 2025$9.47B+2.3%
- 2024$9.26B+8.3%
- 2023$8.54B+5.7%
- 2022$8.08B+3.9%
- 2021$7.78B+16.5%
- 2020$6.67B+6.6%
- 2019$6.26B+7.5%
- 2018$5.83B+9.8%
- 2017$5.31B+8.6%
- 2016$4.89B+2.6%
- 2015$4.76B-0.4%
- 2014$4.79B+4.9%
- 2013$4.56B+5.2%
- 2012$4.34B+2.4%
- 2011$4.23B+18.2%
- 2010$3.58B+29.8%
- 2009$2.76B—
Revenue values are taken from Zoetis's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's current revenue (TTM) is $9.51B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Zoetis (ZTS) revenue is $9.47B – edged up 2.3% year-over-year.
Across 2020–2025 (5 years), Zoetis revenue produced a CAGR of +7.2% – sustaining 10 straight years of year-over-year growth.
2025 marks the peak revenue at $9.47B, with the historical low of $2.76B recorded in 2009.
Zoetis Revenue by Year
Zoetis Revenue 2025: $9.47B
2025's revenue for Zoetis came in at $9.47B, edged up 2.3% from 2024. This figure represents the highest annual value in the available history.
Zoetis Revenue 2024: $9.26B
Zoetis posted revenue of $9.26B in 2024, grew 8.3% from 2023.
Zoetis Revenue 2023: $8.54B
In 2023, Zoetis reported revenue of $8.54B, grew 5.7% from 2022.
Zoetis Revenue 2022: $8.08B
Zoetis revenue in 2022 was $8.08B, edged up 3.9% from 2021.
Zoetis Revenue 2021: $7.78B
Zoetis revenue in 2021 was $7.78B.
See more financial history for Zoetis (ZTS).
Sector peers by Revenue
Healthcare peers of Zoetis (ZTS), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation